Agreed. I think this is half the problem at least. Perhaps we should be looking elsewhere, yes I have no doubt we could easily recruit in the USA with financial inducements and it is the intent to run the 2nd trial there, but although there are regulatory hurdles to overcome maybe the 1st trial should be considered for there also. Alternatively, Eastern Europe ( with financial inducements). I am invested in one ASX biotech now that has done its first clinical trials in an East European country to assess safety, the trial was done in next to no time and no probs getting recruitment, was successful, and today based on that the USA FDA has approved further trialling ( in the USA) as reported in todays announcement. Now thats how you do it !!!
IBX Price at posting:
7.3¢ Sentiment: Hold Disclosure: Held
